BridgeMD
Compares treatment options for Postoperative Pain
Official title Analgesic Efficacy of Ultrasound-guided External Oblique Intercostal Plane Block Versus Posterior Transversus Abdominis Plane Block in Patients Undergoing Open Nephrectomy
ClinicalTrials.gov ID: NCT06892743
What this study is testing
- What it's testing
- Renal cell carcinoma (RCC) accounts for 2-3% of all cancers and is a common malignancy of the genitourinary tract. Open nephrectomy, performed through midline, subcostal, or flank incisions, remains a standard treatment but often results in significant postoperative pain, leading to respiratory muscle dysfunction, increased pulmonary complications, and prolonged hospital stays.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Patients whom diagnosed as having renal carcinoma and scheduled for open nephrectomy under general anesthesia.
- ASA class II- III.
- Age ≥ 18 and ≤ 70 years.
- Body mass index (BMI) less than 40kg/m2.
You likely can't join if
- Patient refusal.
- Hepatic and renal insufficiency.
- Unstable cardiovascular or pulmonary disease.
- History of psychiatric and cognitive disorders.
- Patients with known sensitivity or contraindications to the drug used.
- Patients on regular opioid consumption.
The study team makes the final eligibility decision.
Where it's taking place
- Maadi, Cairo Governorate, Egypt
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maadi, Cairo Governorate, Egypt; Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.